Trust Size
$139M
What Happened
Ibere Pharmaceuticals filed its S-1 registration in 2021. The company was delisted from exchanges with 51 SEC filings on record.
Ibere Pharmaceuticals entered the SPAC market in 2021 with its initial S-1 filing with the SEC, joining the wave of blank check companies seeking acquisition targets.
SEC records show 51 total filings, including annual (10-K) and quarterly (10-Q) financial reports.
The company's last SEC filing was 2023-03-13, and it appears to have been delisted from exchanges â a common fate for SPACs that fail to meet listing requirements or generate sufficient shareholder interest.
The company was incorporated in Cayman Islands.
Timeline
2021-02-22
S-1 Registration Filed
2023-03-13
Last SEC Filing
SEC Filing Details
CIK Number
1835205
Total SEC Filings
51
State of Incorporation
E9
Last Filing Date
2023-03-13
Business Location
Philadelphia, PA
Trust/Asset Size
$139M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
ð SEC Filings
View all EDGAR filings for Ibere Pharmaceuticals